Viral & Non-Viral Vector Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Vector Type (Viral Vector v/s Non-Viral Vector), By Indication (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Diseases, Others), By Application (Gene Therapy, Vaccinology, Cell Therapy, Others), By Company and By Region
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationViral & Non-Viral Vector Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Vector Type (Viral Vector v/s Non-Viral Vector), By Indication (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Diseases, Others), By Application (Gene Therapy, Vaccinology, Cell Therapy, Others), By Company and By Region
The global viral & non-viral vector manufacturing market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include rising prevalence of fatal diseases, growing prominence of gene and cell therapy products, and extensive development in technology, are propelling the growth of the market. Vectors are tools for gene delivery, which deliver genetic material into the nucleic cell. They are of two types, viral and non-viral vectors. Viral vectors are commonly used delivery vehicle in FDA approved gene therapies, whereas non-viral are still studied for their safety and efficacy. The other factors supporting the market’s growth are, the extensive research and development, increasing number of patients, increasing number of clinical studies, various investments by private as well public sectors, increasing prevalence of vector-based gene and cell treatments, the growing number of collaborations between companies, and the high demand for customized medications.
Rising Prevalence of Fatal Diseases
Growing Prominence of Gene and Cell Therapy Products
For instance, in 2022, the USFDA approved second CAR-T therapy named CARVYKTIâ„¢, developed by Johnson and Johnson, which is used for the treatment of relapsed or refractory multiple myeloma.
Market Segmentation
Market Players
Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica plc, Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc
| Attribute | Details |
| Base Year | 2021 |
| Historic Data | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027 |
| Report coverage | Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends |
| Segments covered | · Vector Type · Indication · Application · Company |
| Regional scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; China; India; Japan; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; South Africa; UAE; Saudi Arabia; South Africa; Australia; |
| Key companies profiled | Catalent, Inc., FUJIFILM Holdings Corporation, Danaher Corporation, Genscript Biotech Corporation, Lonza Group AG, Merck KGaA Inc., Oxford Biomedica plc, Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy